Buscar
Mostrando ítems 1-10 de 53
Ovarian hyperstimulation syndrome: pathophysiology and prevention
(SPRINGER/PLENUM PUBLISHERS, 2010)
To review and discuss the pathophysiology and prevention strategies for ovarian hyperstimulation syndrome (OHSS), which is a condition that may occur in up to 20% of the high risk women submitted to assisted reproductive ...
Cholesterol Characterization Of Human Follicular Fluids From Patients At Risk Of Developing Ovarian Hyperstimulation Syndrome (Ohss)
(2016)
OHSS is a complication of ovarian stimulation with gonadotropins following human chorionic gonadotropin (hCG) administration. Enlarged ovaries, increased vascular permeability and excessive production of steroid hormones ...
The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study
(Informa Healthcare, 2013-03-01)
The aim of this study was to evaluate the effects of bromocriptine on vascular endothelial growth factor (VEGF) levels in serum, kidney function and ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. ...
Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
(Elsevier, 2014-08)
The relationship between human chorionic gonadotropin and ovarian hyperstimulation syndrome (OHSS) is partially mediated by vascular endothelial growth factor A (VEGF). The aim of this study was to investigate the effects ...
Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome
(Elsevier Ireland, 2011-03)
Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation with gonadotropins followed by the administration of human chorionic gonadotropin (hCG) to trigger the final steps of oocyte maturation. ...
Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome
(Oxford University Press, 2016-12-07)
re follicular fluid (FF) sphingosine-1-phosphate (S1P) levels in patients at risk of developing ovarian hyperstimulation syndrome (OHSS) altered and in part responsible for the high vascular permeability observed in these ...
Platelet-derived growth factor B restores vascular barrier integrity and diminishes permeability in ovarian hyperstimulation syndrome
(Oxford University Press, 2020-05)
Although advances in the prediction and management of OHSS have been introduced, complete prevention has not been possible yet. Previously, we and other authors have shown that VEGF, ANGPTs and S1P are involved in OHSS ...
Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study
(BioMed Central, 2013-09)
Background: In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian ...